Who has invested in Kojin Therapeutics?

Polaris Partners, Newpath Partners, Cathay Health, Leaps by Bayer, AbbVie, Eventide Asset Management are named among the investors backing Kojin Therapeutics.

Kojin Therapeutics Funding: $60M Raised, Series A (2021)

Kojin Therapeutics funding overview

Kojin Therapeutics is based in Cambridge, Massachusetts. Kojin Therapeutics has raised $60M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in June 2021. The round record for Kojin Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include Polaris Partners, Newpath Partners, Cathay Health, Leaps by Bayer, AbbVie, Eventide Asset Management and 2 others. 8 distinct backers are named across the disclosed rounds.

Kojin Therapeutics at a glance

Total raised: $60M
Latest round: Series A
Latest round date: June 2021
Headquarters: Cambridge, Massachusetts
Notable investors: Polaris Partners, Newpath Partners, Cathay Health, Leaps by Bayer, AbbVie, Eventide Asset Management, Alexandria, Dana-Farber Cancer Institute’s Binney Street Capital

Frequently asked about Kojin Therapeutics funding

How much has Kojin Therapeutics raised?: Kojin Therapeutics has raised $60M in total disclosed funding across the rounds on record.
Who has invested in Kojin Therapeutics?: Polaris Partners, Newpath Partners, Cathay Health, Leaps by Bayer, AbbVie, Eventide Asset Management are named among the investors backing Kojin Therapeutics.
What was the latest Kojin Therapeutics funding round?: The most recent disclosed round is a Series A, announced in June 2021.
Where is Kojin Therapeutics based?: Kojin Therapeutics is based in Cambridge, Massachusetts.
When did Kojin Therapeutics last raise?: The last disclosed Kojin Therapeutics round closed in June 2021 at Series A.

Kojin Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Cambridge below to benchmark round size and investor mix.

Kojin Therapeutics Funding: $60M Raised, Series A (2021)

Kojin Therapeutics funding overview

Kojin Therapeutics at a glance

Frequently asked about Kojin Therapeutics funding

Companies related to Kojin Therapeutics (35)

Browse related funding lists (9)